Latest News & Features
Americas
Pharma group strikes an all-cash transaction, combining a portfolio expansion with a contingent payment linked to a dispute over a $5 billion drug 28 April 2026
Americas
BioNTech’s former rival—now part of its company—is seeking to assert its mRNA portfolio against Moderna in a new suit over modifications to the highly fought-over molecule. 28 April 2026
Americas
An event for IP, legal and compliance leaders to address the growing threat of trade secret misappropriation heads to San Jose. 28 April 2026
Europe
An opinion has put pressure on the CJEU to clarify a long-running grey area that could change the game for how drug makers secure supplementary protection certificates across Europe. 24 April 2026
Americas
The US pharma giant is spending up to $1 billion to build an end-to-end biosimilar platform and is counting on a decade of expiring biologic patents to make it pay off. 23 April 2026
Americas
Plaintiff alleges that a $6 billion rival probed its records system via a long-term customer, using confidential information to develop its product in the behavioural health tech space. 23 April 2026
Americas
Decision underscores a growing deference to parallel rulings and tighter control over duplicate patent challenges. 22 April 2026
Careers
A New Jersey firm appoints the high-stakes litigator as chair of its trademarks, trade secrets and copyright practice, bringing experience across patent, trade secret, trademark, trade dress, and copyright disputes. 21 April 2026
Europe
With the start of the first-ever INTA Annual Meeting held in the UK capital just weeks away, in-house IP counsel share their favourite ways to spend downtime in the city. 21 April 2026
Americas
The maker of a cosmetic penile implant has suffered at the Federal Circuit, after a ruling said its trade secrets claims are not protectable while leaving a counterfeiting finding intact. 20 April 2026